基质金属蛋白酶在脑胶质细胞瘤研究中的应用前景
被引量:2
出处
《中华神经外科疾病研究杂志》
CAS
2006年第2期183-186,共4页
Chinese Journal of Neurosurgical Disease Research
基金
国家自然科学基金资助项目(30370512)
参考文献52
-
1章翔.肿瘤类型与分布[A].见: 章翔主编.神经系统肿瘤学 [M](第1版)[C].北京: 军事医学科学出版社,1999.8-10.
-
2Shingleton WD,Hodges DJ,Brick P,et al.Collagenase:a key enzyme in collagen turnover[J].Biochem Cell Biol,1996,74(6):759-775.
-
3Aimes RT,Quigley JP.Matrix metalloproteinase-2 is an interstitial collagenase.Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4-and -length fragments[J].J Biol Chem,1995,270(11):5872-5876.
-
4Egeblad M,Werb Z.New functions for the matrix metalloproteinases in cancer progression[J].Nat Rev Cancer,2002,2(3):161-174.
-
5Overall CM,Lopez-Otin C.Strategies for MMP inhibition in cancer:innovations for the post-trial era[J].Nat Rev Cancer,2002,2(9):657-672.
-
6Zucker S,Cao J,Chen WT.Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment[J].Oncogene,2000,19(56):6642-6650.
-
7Coussens LM,Fingleton B,Matrisian LM.Matrix metalloproteinase inhibitors and cancer:trials and tribulations[J].Science,2002,295(5564):2387-2392.
-
8Zucker S,Hymowitz M,Conner C,et al.Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in blood and tissues.Clinical and experimental applications[J].Ann N Y Acad Sci,1999,878:212-227.
-
9Nikkola J,Vihinen P,Vlaykova T,et al.High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma[J].Int J Cancer,2002,97(4):432-438.
-
10Loffek S,Zigrino P,Angel P,et al.High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1 and basic fibroblast growth factor-mediated mechanisms[J].J Invest Dermatol,2005,124(3):638-643.
共引文献2
-
1陈谦学,邵步云,黄乔春,王军民,阮航,郑虎,吴立权.MMP-2及TGF-β_1在人脑胶质瘤中的表达及意义[J].中国临床神经外科杂志,2004,9(6):414-416.
-
2牛光明,万锋,雷霆,薛德麟.CD44s和MT1-MMPmRNA在人脑胶质瘤中的表达及其意义[J].中国临床神经外科杂志,2004,9(6):420-421.
同被引文献27
-
1Sounni NE, Janssen M, Foidart JM, et al. Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis [J]. Matrix Biol, 2003, 22(1) :55-61.
-
2Neslon AR, Fingleton B, Bothenberg ML, et al. Matrix metalloproteinases:' biologic activity and clinical implications[J]. J Clin Oncol, 2000, 18(5) : 1135-1149.
-
3Thier M, Roeb E, Breuer B, et al. Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines., inverse correlation with proliferation rate [J]. Cancer Lett, 2000, 149 (1- 2) :163-170.
-
4Lu KV, Jong KA, Rajasekaran AK, et al. Upregulatio of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix mefalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line [J]. Lab Invest, 2004, 84(1):8-20.
-
5Platten M, Wick W, Weller M. Malignant glioma biology: role for TGF-β in growth, motility, angiogenesis and immune escape [J]. Microsc Res Tech, 2001, 52(4):401-410.
-
6Arato-Ohshima T, Sawa H. Over-expression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility [J]. Int J Cancer, 1999, 83(3) :387-392.
-
7Takahashi M, Fukami S, Iwata, et al. In vivo glioma growth requires host-derived matrix metalloproteinase-2 for maintenance of angioarchitecture [J]. Pharmacol Res, 2002, 46(2) :155-163.
-
8Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family [ J ]. J Biol Chem, 1993, 268(34): 25803-25810.
-
9Fusetti F, Pijning T, Kalk KH, et al. Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39 [J]. J Biol Chem, 2003, 278(39) : 37753 -37760.
-
10Houston DR, Recklies AD, Krupa JC, et al. Structure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes [J]. J Biol Chem, 2003, 278(32) : 30206 -30212.
引证文献2
-
1周任,柏鲁宁,王睿智,张龙洲,包新杰,曹杰.基质金属蛋白酶-2及其抑制因子TIMP-2在脑胶质瘤中的表达及意义[J].西安交通大学学报(医学版),2008,29(6):686-688. 被引量:2
-
2陈蔚军,马玉帛,章薇,章翔.YKL-40与中枢神经系统肿瘤[J].中华神经外科疾病研究杂志,2015,14(5):468-470. 被引量:2
二级引证文献4
-
1路艳,张春艳,王聪霞,张岩,朱锦云,高艳华,丁法明,陈俊亮.高糖对MMP-2与TIMP-2的表达及血管平滑肌细胞增殖的影响[J].西安交通大学学报(医学版),2012,33(3):312-315. 被引量:8
-
2黄妍,席志芹,曾昆,钟海,杨虹.血清基质金属蛋白酶1、2、9及基质金属蛋白酶抑制剂1、2在脑胶质瘤诊断中的价值研究[J].中国实验诊断学,2012,16(7):1284-1285.
-
3侯永强,王新征.血清YKL-40蛋白水平与肝硬化患者肝功能、肝纤维化的相关性及作用机制[J].中西医结合肝病杂志,2019,29(5):427-429. 被引量:10
-
4吴洵柱,肖尚文,胡正鲜.经尿道膀胱肿瘤电切术后吉西他滨+表柔比星灌注化疗在非肌层浸润性膀胱癌患者中的应用效果[J].癌症进展,2023,21(3):283-285. 被引量:2
-
1潘雪峰,范乃军,高春芳.LncRNA与结直肠癌诊断治疗的研究进展[J].肿瘤学杂志,2017,23(2):111-115. 被引量:13
-
2治疗白血病特效新药Gleevec面世[J].国际医药卫生导报,2001,7(09B):22-22.
-
3白岚.结直肠癌肝转移的治疗策略[J].现代消化及介入诊疗,2006,11(4):222-224.
-
4余深平,赵晓娟.影像学诊断直肠癌转移淋巴结的研究进展[J].消化肿瘤杂志(电子版),2012,4(1):10-12. 被引量:3
-
5刘秀钦(综述),杨建伟(审校).早期胃癌诊治进展[J].国际肿瘤学杂志,2008,35(7):518-522.
-
6李慧,高重阳,王夏红,赵建民.DSA诊断颅内动脉瘤的临床研究[J].中国实用神经疾病杂志,2009,12(21):27-28. 被引量:2
-
7赵文华,于起涛.抗PD-1/PD-L1单抗在非小细胞肺癌治疗中的研究进展[J].广西医科大学学报,2016,33(3):553-557. 被引量:7
-
8张金库.基质金属蛋白酶及其抑制剂与肿瘤关系的研究进展[J].诊断病理学杂志,2004,11(4):269-271. 被引量:7
-
9刘旭,张春艳,张月桂,唐雅丽,李殿俊,李秀芳,王者英,王惠增,史文举.国产rIL-2治疗恶性肿瘤的基础与临床应用研究[J].中国肿瘤生物治疗杂志,1995,2(4):279-280. 被引量:1
-
10彭淞.左半结肠癌伴急性梗阻的临床诊治体会[J].中国实用医药,2014,9(23):93-94.